Cost-Effectiveness of Treating Patients with Chronic Kidney Disease and Prior Hyperkalemia with Renin–Angiotensin–Aldosterone System Inhibitor and Patiromer: A Swiss Public Healthcare Perspective

被引:0
|
作者
Barbara Fischer
Andreas Serra
Harry Telser
机构
[1] Polynomics,Department of Internal Medicine and Nephrology
[2] Klinik Hirslanden,Center for Health, Policy and Economics
[3] University of Lucerne,undefined
来源
Advances in Therapy | 2022年 / 39卷
关键词
Chronic kidney disease; Hyperkalemia; Patiromer; Potassium binder;
D O I
暂无
中图分类号
学科分类号
摘要
引用
收藏
页码:2717 / 2730
页数:13
相关论文
共 50 条
  • [21] The effect of renin-angiotensin system blockade on renal protection in chronic kidney disease patients with hyperkalemia
    Lee, Ju-Hyun
    Kwon, Young Eun
    Park, Jung Tak
    Lee, Mi Jung
    Oh, Hyung Jung
    Han, Seung Hyeok
    Kang, Shin-Wook
    Choi, Kyu Hun
    Yoo, Tae-Hyun
    JOURNAL OF THE RENIN-ANGIOTENSIN-ALDOSTERONE SYSTEM, 2014, 15 (04) : 491 - 497
  • [22] Hyperkalemia: A Cause of Non-adherence to Renin-Angiotensin-Aldosterone System Inhibitors in Chronic Kidney Disease: A Retrospective Study
    Gulcicek, Sibel
    Seyahi, Nurhan
    ISTANBUL MEDICAL JOURNAL, 2023, 24 (04): : 404 - 411
  • [24] EFFECTS OF THE DIRECT RENIN INHIBITOR ON RENIN-ANGIOTENSIN SYSTEM IN HYPERTENSIVE PATIENTS WITH CHRONIC KIDNEY DISEASE
    Kanako, Bokuda
    Satoshi, Morimoto
    Masaki, Ryuzaki
    Yuuki, Mizuguchi
    Yoichi, Oshima
    Michita, Niiyama
    Yasufumi, Seki
    Naohiro, Yoshida
    Daisuke, Watanabe
    Fumiko, Mori
    Takashi, Ando
    Masami, Ono
    Hiroshi, Itoh
    Atsuhiro, Ichihara
    NEPHROLOGY, 2014, 19 : 33 - 33
  • [25] Prescription of renin-angiotensin-aldosterone system blockers in patients with stage 3 chronic kidney disease
    Alvarez, Marcel
    Ardiles, Leopoldo
    REVISTA MEDICA DE CHILE, 2019, 147 (02) : 173 - 180
  • [26] Treatment effects of renin-angiotensin aldosterone system blockade on kidney failure and mortality in chronic kidney disease patients
    Vejakama, Phisitt
    Ingsathit, Atiporn
    McKay, Gareth J.
    Maxwell, Alexander P.
    McEvoy, Mark
    Attia, John
    Thakkinstian, Ammarin
    BMC NEPHROLOGY, 2017, 18
  • [27] Treatment effects of renin-angiotensin aldosterone system blockade on kidney failure and mortality in chronic kidney disease patients
    Phisitt Vejakama
    Atiporn Ingsathit
    Gareth J. McKay
    Alexander P. Maxwell
    Mark McEvoy
    John Attia
    Ammarin Thakkinstian
    BMC Nephrology, 18
  • [28] Maintaining renin-angiotensin-aldosterone system inhibitor treatment with patiromer in hyperkalaemic chronic kidney disease patients: comparison of a propensity-matched real-world population with AMETHYST-DN
    Chinnadurai, Rajkumar
    Rengarajan, Sharmilee
    Budden, Jeffrey J.
    Quinn, Carol Moreno
    Kalra, Philip A.
    AMERICAN JOURNAL OF NEPHROLOGY, 2023, 54 (9-10) : 408 - 415
  • [29] Cost-effectiveness of sodium zirconium cyclosilicate for the treatment of hyperkalemia in patients with chronic kidney disease or heart failure in Spain
    Alcazar-Arroyo, Roberto
    Crespo-Leiro, Maria G.
    Bover, Jordi
    Oliva, Juan
    Sequera-Mutiozabal, Miren
    Gradari, Simona
    Marinez-Lopez, Anisia
    Lopez-Chicheri, Blanca
    Vidal-Vilar, Neus
    Aceituno, Susana
    Cobo, Marta
    NEFROLOGIA, 2024, 44 (05): : 709 - 720
  • [30] Safety of enhanced renin-angiotensin-aldosterone system inhibition with aliskiren in nondiabetic patients with chronic kidney disease
    Lizakowski, Slawomir
    Tylicki, Leszek
    Rutkowski, Przemyslaw
    Renke, Marcin
    Sulikowska, Beata
    Heleniak, Zbigniew
    Donderski, Rafal
    Bednarski, Rafal
    Przybylska, Milena
    Manitius, Jacek
    Rutkowski, Boleslaw
    POLSKIE ARCHIWUM MEDYCYNY WEWNETRZNEJ-POLISH ARCHIVES OF INTERNAL MEDICINE, 2013, 123 (05): : 221 - 227